Erratum: Identification of a μ-δ opioid receptor heteromerbiased agonist with antinociceptive activity (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (12072-12077) DOI: 10.1073/pnas.1222044110);Identification of a μ-δ opioid receptor heteromerbiased agonist with antinociceptive activity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 29, 2013, Pages 12072-12077

  Gomes, Ivone ^a   Fujita, Wakako ^a   Gupta, Achla ^a   Saldanha, Adrian S ^b   Negri, Ana ^c   Pinello, Christine E ^b   Roberts, Edward ^d   Filizola, Marta ^c   Hodder, Peter ^b   Devi, Lakshmi A ^a  

^a Translational Research Institute   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA ARRESTIN; CYM 51010; DELTA OPIATE RECEPTOR AGONIST; DIMER; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG TARGETING; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

EID: 84880363091     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317238110     Document Type: Erratum

References (16)

1. Li M, et al. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288(5464):335-339.
2. Graves JD, et al. (1998) Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 17(8):2224-2234.
3. Hara T, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441(7095):885-889.
4. Hetz C, et al. (2009) XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23(19):2294-2306.
5. Sasaki S (2011) Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 70(5):349-359.
6. Levine B, Klionsky DJ (2004) Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 6(4):463-477.
7. Kabeya Y, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19(21):5720-5728.
8. Klionsky DJ, et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4(2):151-175.
9. Bjørkøy G, et al. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171(4):603-614.
10. Turner BJ, Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85(1):94-134.
11. Beal MF, et al. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42(4):644-654.
12. Bogdanov M, et al. (2000) Increased oxidative damage to DNA in ALS patients. Free Radic Biol Med 29(7):652-658.
13. Ferrante RJ, et al. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69(5):2064-2074.
14. Oh S, et al. (2009) Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol 29(23):6309-6320.
15. Shin JH, et al. (2007) Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol Pharmacol 71(4):965-975.
16. Vandeputte C, et al. (2010) Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 11:92.